{"id":"LEG-2425-003-S","is_published":"2024-05-15T12:57:09.000000Z","release_date":"2024-05-15T13:00:00.000000Z","updated_at":"2024-05-15T12:57:09.000000Z","type":"LEG","internal_id":"LEG-2425-003-S","title_en":"An Act respecting pharmacare","title_fr":"Loi concernant l\u2019assurance m\u00e9dicaments","slug":"LEG-2425-003-S--an-act-respecting-pharmacare--loi-concernant-assurance-medicaments","permalinks":{"en":{"website":"https:\/\/www.pbo-dpb.ca\/en\/publications\/LEG-2425-003-S--an-act-respecting-pharmacare--loi-concernant-assurance-medicaments","preview":"https:\/\/www.pbo-dpb.ca\/en\/publications\/LEG-2425-003-S--an-act-respecting-pharmacare--loi-concernant-assurance-medicaments"},"fr":{"website":"https:\/\/www.pbo-dpb.ca\/fr\/publications\/LEG-2425-003-S--an-act-respecting-pharmacare--loi-concernant-assurance-medicaments","preview":"https:\/\/www.pbo-dpb.ca\/fr\/publications\/LEG-2425-003-S--an-act-respecting-pharmacare--loi-concernant-assurance-medicaments"}},"artifacts":{"main":{"en":{"public":"https:\/\/distribution-a617274656661637473.pbo-dpb.ca\/717eaf4e6e546078e4babb78d55f1abb6fec87ecb520e4c6e6594af644cb77bb"},"fr":{"public":"https:\/\/distribution-a617274656661637473.pbo-dpb.ca\/748f70ad33251c83f29009b45288e9641384cbeb3c20ae6563d7aa9d49055de5"}}},"coverpages":{"distribution":{"fr":{"small":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/ee21504dd0b61892a2d137b4e831c1f664509f81cc22890099be64bdefca2bd7","large":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/70286776e5f29dc80ebe0f6fd072f28feca4772e7366c9b2fb698917a36f6eb2","h150_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/452891b428e1c4b1141efe14ea71221f61443a798223b03b4349110c6a27b267","h150_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/c371059227d91715668e745bf598da99d1b6849d682467f28217a1c4418f9116","h300_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/eb82b4e867e3d9de21be6711ac73695a3bba57962bdd6d1fb56f0184dbd7d27b","h300_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/78688d2afd01bcfa147b3bee74a033393cd106533323ddccb758ecae35c1df60","h600_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/8267532fbacf2eba00256d112d5690d49e74b5bf67b3e2f6488b175f5c5daada","h600_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/6637dc33f28cc6d2cd1dedfdb696832c41c7c0031e32972c7233bd27b910513b"},"en":{"small":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/3be41e060c0ba05d753356851403c8d600e1c568a0bcf61f0a06ea5bbd1ba6c9","large":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/cecf8963cc3c346d846bf583364609694b512e0cf7d9186f86921c1e017dc7bb","h150_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/a3aa3a246615999c04c4915deb094c91b6eeb50baa2761e82a7098a609694a08","h150_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/3339fdf15174280824b5ee2445d3f503d88bf1fd3021e1c4d286e3777ce0bb29","h300_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/98d470604f0cb862c6f5b359194320364256a47db0670ba6d5df7ededaf76d82","h300_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/0d769746a60b5a0e9e93449df0912955a890847a9c5d26a19472c38f57decaba","h600_png_optimized":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/b01e9f10a24343d2dc10e527ac12b3cb1268bbd8cd68662d40458a146df05589","h600_webp":"https:\/\/distribution-i696d61676573.pbo-dpb.ca\/37529935a2af2d31506cc64455ecd1bca19c70d1fc7cf9e72071f68d71d615a0"}}},"metadata":{"abstract_en":"Bill C-64 proposes to provide universal, single-payer, first-dollar coverage for a range of contraception and diabetes medications as the first phase of national universal pharmacare. The aim of the program is to expand and enhance, rather than replace, existing provincial and territorial coverage.\n\nThe PBO estimates that the first phase of national universal pharmacare will increase federal program spending by $1.9 billion over five years. This estimate assumes that any medications that are currently covered by provincial and territorial governments, as well as private insurance providers will remain covered on the same terms.","abstract_fr":"\u00c0 titre de premi\u00e8re phase d\u2019un r\u00e9gime d\u2019assurance m\u00e9dicaments national et universel, le projet de loi C-64 propose d\u2019offrir une couverture universelle au premier dollar \u00e0 payeur unique pour divers m\u00e9dicaments contraceptifs et pour le traitement du diab\u00e8te. Le programme vise \u00e0 bonifier et \u00e9largir, et non pas remplacer la couverture provinciale et territoriale.\n\nLe DPB estime que la premi\u00e8re phase du r\u00e9gime d\u2019assurance m\u00e9dicaments national universel augmentera les d\u00e9penses du programme f\u00e9d\u00e9ral de 1,9 milliard de dollars sur cinq ans. Cette estimation suppose que les m\u00e9dicaments actuellement couverts par les gouvernements provinciaux et territoriaux, ainsi que par les assureurs priv\u00e9s, resteront couverts aux m\u00eames conditions.","highlights":[]},"bills":[{"id":548,"created_at":"2024-02-29T14:00:08-05:00","updated_at":"2024-09-12T13:47:28-04:00","legisid":"44_1_C-64","parliament":44,"session":1,"prefix":"C","number":64,"title_en":"An Act respecting pharmacare","title_fr":"Loi concernant l\u0027assurance m\u00e9dicaments","bill_num":"C-64","permalinks":{"en":{"website":"https:\/\/www.pbo-dpb.ca\/en\/bills--projets-de-loi\/44-1\/C-64","legisinfo":"https:\/\/www.parl.ca\/legisinfo\/en\/bill\/44-1\/c-64"},"fr":{"website":"https:\/\/www.pbo-dpb.ca\/fr\/bills--projets-de-loi\/44-1\/C-64","legisinfo":"https:\/\/www.parl.ca\/LegisInfo\/fr\/projet-de-loi\/44-1\/c-64"}},"pivot":{"publication_id":801,"bill_id":548}}],"bibtex":{"en":"@techreport{PBO-LEG2425003S,\n author={Barkova, Lisa},\n title={An Act respecting pharmacare},\n institution={The Office of the Parliamentary Budget Officer},\n year=2024,\n \n address = \u0022Ottawa, ON\u0022\n}","fr":"@techreport{DPB-LEG2425003S,\n author={Barkova, Lisa},\n title={Loi concernant l\u2019assurance m\\\u0027{e}dicaments},\n institution={Bureau du directeur parlementaire du budget},\n year=2024,\n \n address = \u0022Ottawa, ON\u0022\n}"}}
